13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.

S Graf; M Nikfardjam; A Khorsand; S Ofluoglu; S Nekolla; R Dudczak; G Maurer; K Kletter; K Huber; Christian Pirich

13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.

S Graf
, M Nikfardjam
, A Khorsand
, S Ofluoglu
, S Nekolla
, R Dudczak
, G Maurer
, K Kletter
, K Huber
, Christian Pirich (Letztautor/-in)

Universitätsklinikum für Nuklearmedizin und Endokrinologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	248-253
Fachzeitschrift	NUKLEARMEDIZIN-NUCLEAR MEDICINE
Jahrgang	45
Ausgabenummer	6
Publikationsstatus	Veröffentlicht - 2006

Dieses zitieren

Graf, S., Nikfardjam, M., Khorsand, A., Ofluoglu, S., Nekolla, S., Dudczak, R., Maurer, G., Kletter, K., Huber, K., & Pirich, C. (2006). 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels. NUKLEARMEDIZIN-NUCLEAR MEDICINE , 45(6), 248-253.

Graf, S ; Nikfardjam, M ; Khorsand, A et al. / 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels. in: NUKLEARMEDIZIN-NUCLEAR MEDICINE 2006 ; Jahrgang 45, Nr. 6. S. 248-253.

@article{8c5846e2592d4277a0753014ac76c8f5,

title = "13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, MYOCARDIAL BLOOD-FLOW, ENDOTHELIUM-DEPENDENT VASODILATION, PLASMA HOMOCYSTEINE, VASCULAR-DISEASE, LOWERING THERAPY, N-13 AMMONIA, RISK FACTOR, CONTROLLED-TRIAL, HEALTHY-ADULTS",

author = "S Graf and M Nikfardjam and A Khorsand and S Ofluoglu and S Nekolla and R Dudczak and G Maurer and K Kletter and K Huber and Christian Pirich",

year = "2006",

language = "English",

volume = "45",

pages = "248--253",

journal = "NUKLEARMEDIZIN-NUCLEAR MEDICINE ",

issn = "0029-5566",

publisher = "Thieme Medical Publishers, US ",

number = "6",

}

Graf, S, Nikfardjam, M, Khorsand, A, Ofluoglu, S, Nekolla, S, Dudczak, R, Maurer, G, Kletter, K, Huber, K & Pirich, C 2006, '13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.', NUKLEARMEDIZIN-NUCLEAR MEDICINE , Jg. 45, Nr. 6, S. 248-253.

13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels. / Graf, S; Nikfardjam, M; Khorsand, A et al.
in: NUKLEARMEDIZIN-NUCLEAR MEDICINE , Jahrgang 45, Nr. 6, 2006, S. 248-253.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.

AU - Graf, S

AU - Nikfardjam, M

AU - Khorsand, A

AU - Ofluoglu, S

AU - Nekolla, S

AU - Dudczak, R

AU - Maurer, G

AU - Kletter, K

AU - Huber, K

AU - Pirich, Christian

PY - 2006

Y1 - 2006

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - MYOCARDIAL BLOOD-FLOW

KW - ENDOTHELIUM-DEPENDENT VASODILATION

KW - PLASMA HOMOCYSTEINE

KW - VASCULAR-DISEASE

KW - LOWERING THERAPY

KW - N-13 AMMONIA

KW - RISK FACTOR

KW - CONTROLLED-TRIAL

KW - HEALTHY-ADULTS

M3 - Original Article

C2 - 17149493

SN - 0029-5566

VL - 45

SP - 248

EP - 253

JO - NUKLEARMEDIZIN-NUCLEAR MEDICINE

JF - NUKLEARMEDIZIN-NUCLEAR MEDICINE

IS - 6

ER -

Graf S, Nikfardjam M, Khorsand A, Ofluoglu S, Nekolla S, Dudczak R et al. 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels. NUKLEARMEDIZIN-NUCLEAR MEDICINE . 2006;45(6):248-253.